These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 27450031)

  • 1. Hypofrontality and Posterior Hyperactivity in Early Schizophrenia: Imaging and Behavior in a Preclinical Model.
    Kaneko G; Sanganahalli BG; Groman SM; Wang H; Coman D; Rao J; Herman P; Jiang L; Rich K; de Graaf RA; Taylor JR; Hyder F
    Biol Psychiatry; 2017 Mar; 81(6):503-513. PubMed ID: 27450031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Memory deficits with intact cognitive control in the methylazoxymethanol acetate (MAM) exposure model of neurodevelopmental insult.
    O'Reilly KC; Perica MI; Fenton AA
    Neurobiol Learn Mem; 2016 Oct; 134 Pt B(Pt B):294-303. PubMed ID: 27485950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural abnormalities revealed by magnetic resonance imaging in rats prenatally exposed to methylazoxymethanol acetate parallel cerebral pathology in schizophrenia.
    Chin CL; Curzon P; Schwartz AJ; O'Connor EM; Rueter LE; Fox GB; Day M; Basso AM
    Synapse; 2011 May; 65(5):393-403. PubMed ID: 20803618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MAM (E17) rodent developmental model of neuropsychiatric disease: disruptions in learning and dysregulation of nucleus accumbens dopamine release, but spared executive function.
    Howe WM; Tierney PL; Young DA; Oomen C; Kozak R
    Psychopharmacology (Berl); 2015 Nov; 232(21-22):4113-27. PubMed ID: 25963563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of the MAM model of schizophrenia in mice: Sex similarities and differences of hippocampal and prefrontal cortical function.
    Chalkiadaki K; Velli A; Kyriazidis E; Stavroulaki V; Vouvoutsis V; Chatzaki E; Aivaliotis M; Sidiropoulou K
    Neuropharmacology; 2019 Jan; 144():193-207. PubMed ID: 30366002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive performance of the MAM-E17 schizophrenia model rats in different age-periods.
    Kállai V; Lénárd L; Péczely L; Gálosi R; Dusa D; Tóth A; László K; Kertes E; Kovács A; Zagoracz O; Berta B; Karádi Z; Ollmann T
    Behav Brain Res; 2020 Feb; 379():112345. PubMed ID: 31704232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: implications for the neuropathology of schizophrenia.
    Moore H; Jentsch JD; Ghajarnia M; Geyer MA; Grace AA
    Biol Psychiatry; 2006 Aug; 60(3):253-64. PubMed ID: 16581031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gestational methylazoxymethanol acetate treatment impairs select cognitive functions: parallels to schizophrenia.
    Featherstone RE; Rizos Z; Nobrega JN; Kapur S; Fletcher PJ
    Neuropsychopharmacology; 2007 Feb; 32(2):483-92. PubMed ID: 17035930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [MAM-E17 schizophrenia rat model].
    Kállai V; Tóth A; Gálosi R; Szabó I; Petykó Z; Karádi Z; Kállai J; Lénárd L
    Psychiatr Hung; 2015; 30(1):4-17. PubMed ID: 25867884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early-Stage Repetitive Transcranial Magnetic Stimulation Altered Posterior-Anterior Cerebrum Effective Connectivity in Methylazoxymethanol Acetate Rats.
    Guo H; Xiao Y; Sun D; Yang J; Wang J; Wang H; Pan C; Li C; Zhao P; Zhang Y; Wu J; Zhang X; Wang F
    Front Neurosci; 2021; 15():652715. PubMed ID: 34093113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormalities in behaviour, histology and prefrontal cortical gene expression profiles relevant to schizophrenia in embryonic day 17 MAM-Exposed C57BL/6 mice.
    Huo C; Liu X; Zhao J; Zhao T; Huang H; Ye H
    Neuropharmacology; 2018 Sep; 140():287-301. PubMed ID: 30056124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decrease in parvalbumin-expressing neurons in the hippocampus and increased phencyclidine-induced locomotor activity in the rat methylazoxymethanol (MAM) model of schizophrenia.
    Penschuck S; Flagstad P; Didriksen M; Leist M; Michael-Titus AT
    Eur J Neurosci; 2006 Jan; 23(1):279-84. PubMed ID: 16420437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral Biomarkers of Schizophrenia in High Drinker Rats: A Potential Endophenotype of Compulsive Neuropsychiatric Disorders.
    Navarro SV; Alvarez R; Colomina MT; Sanchez-Santed F; Flores P; Moreno M
    Schizophr Bull; 2017 Jul; 43(4):778-787. PubMed ID: 27872269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The MAM-E17 schizophrenia rat model: Comprehensive behavioral analysis of pre-pubertal, pubertal and adult rats.
    Kállai V; Tóth A; Gálosi R; Péczely L; Ollmann T; Petykó Z; László K; Kállai J; Szabó I; Karádi Z; Lénárd L
    Behav Brain Res; 2017 Aug; 332():75-83. PubMed ID: 28577920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex differences in neuronal oscillatory activity and memory in the methylazoxymethanol acetate model of schizophrenia.
    Albeely AM; Williams OOF; Blight CR; Thériault RK; Perreault ML
    Schizophr Res; 2024 May; 267():451-461. PubMed ID: 38643726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adolescent Social Isolation Affects Schizophrenia-Like Behavior in the MAM-E17 Model of Schizophrenia.
    Bator E; Latusz J; Głowacka U; Radaszkiewicz A; Mudlaff K; Maćkowiak M
    Neurotox Res; 2018 Aug; 34(2):305-323. PubMed ID: 29536265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prenatal methylazoxymethanol acetate treatment: a neurodevelopmental animal model for schizophrenia?
    Jongen-Rêlo AL; Leng A; Lüber M; Pothuizen HH; Weber L; Feldon J
    Behav Brain Res; 2004 Mar; 149(2):159-81. PubMed ID: 15129780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Social dysfunction in the neurodevelopmental model of schizophrenia in male and female rats: Behavioural and biochemical studies.
    Potasiewicz A; Holuj M; Litwa E; Gzielo K; Socha L; Popik P; Nikiforuk A
    Neuropharmacology; 2020 Jun; 170():108040. PubMed ID: 32165218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproic acid (VPA) reduces sensorimotor gating deficits and HDAC2 overexpression in the MAM animal model of schizophrenia.
    Bator E; Latusz J; Radaszkiewicz A; Wędzony K; Maćkowiak M
    Pharmacol Rep; 2015 Dec; 67(6):1124-9. PubMed ID: 26481530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroimaging of cognitive disability in schizophrenia: search for a pathophysiological mechanism.
    Ragland JD; Yoon J; Minzenberg MJ; Carter CS
    Int Rev Psychiatry; 2007 Aug; 19(4):417-27. PubMed ID: 17671874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.